Cytek Biosciences, Inc.
CTKB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $201M | $200M | +0.5% |
| Operating income | −$40.4M | −$20.5M | −96.8% |
| Net income | −$66.5M | −$6.02M | −1,005% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $53.2M | $52.3M | +1.7% |
| Operating income | −$8.40M | −$9.20M | +8.7% |
| Net income | −$6.10M | −$5.50M | −10.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Cytek Biosciences's revenue in FY2025?
- $201M in FY2025 (Fiscal year ended Dec 31, 2025), +0.5% vs $200M a year earlier, per its 10-K filed Feb 2026.
- Was Cytek Biosciences profitable in FY2025?
- No: net income was −$66.5M and operating income −$40.4M in FY2025.
- What was Cytek Biosciences's revenue in Q3 2026?
- $53.2M (+1.7% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.